GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (HAM:COP) » Definitions » Change In Receivables

CompuGroup Medical SE KgaA (HAM:COP) Change In Receivables : €-31 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is CompuGroup Medical SE KgaA Change In Receivables?

CompuGroup Medical SE KgaA's change in receivables for the quarter that ended in Mar. 2024 was €-52 Mil. It means CompuGroup Medical SE KgaA's Accounts Receivable increased by €52 Mil from Dec. 2023 to Mar. 2024 .

CompuGroup Medical SE KgaA's change in receivables for the fiscal year that ended in Dec. 2023 was €15 Mil. It means CompuGroup Medical SE KgaA's Accounts Receivable declined by €15 Mil from Dec. 2022 to Dec. 2023 .

CompuGroup Medical SE KgaA's Accounts Receivable for the quarter that ended in Mar. 2024 was €216 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CompuGroup Medical SE KgaA's Days Sales Outstanding for the three months ended in Mar. 2024 was 69.30.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CompuGroup Medical SE KgaA's liquidation value for the three months ended in Mar. 2024 was €-1,023 Mil.


CompuGroup Medical SE KgaA Change In Receivables Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Change In Receivables Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.39 -34.24 -20.94 -38.16 15.41

CompuGroup Medical SE KgaA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.90 6.37 10.77 3.18 -51.53

CompuGroup Medical SE KgaA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA  (HAM:COP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CompuGroup Medical SE KgaA's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=216.162/284.624*91
=69.30

2. In Ben Graham's calculation of liquidation value, CompuGroup Medical SE KgaA's accounts receivable are only considered to be worth 75% of book value:

CompuGroup Medical SE KgaA's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=123.599-1316.889+0.75 * 216.162+0.5 * 16.763
=-1,023

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CompuGroup Medical SE KgaA Change In Receivables Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA (HAM:COP) Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.

CompuGroup Medical SE KgaA (HAM:COP) Headlines

From GuruFocus

Q1 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Special Meeting of Stockholders Transcript

By GuruFocus Research 01-22-2024

Conocophillips Analyst & Investor Meeting Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024